Find Semax manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Related ProductsRelated Products

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 80714-61-0, Acth (4-7), pro-gly-pro-, Mehfpgp, Met-glu-his-phe-pro-gly-pro, I5fal2585h, Acth (4-7), prolyl-glycyl-proline-
Molecular Formula
C37H51N9O10S
Molecular Weight
813.9  g/mol
InChI Key
AFEHBIGDWIGTEH-AQRCPPRCSA-N
FDA UNII
I5FAL2585H

Semax
1 2D Structure

Semax

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(2S)-1-[2-[[(2S)-1-[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid
2.1.2 InChI
InChI=1S/C37H51N9O10S/c1-57-16-13-24(38)32(50)42-25(11-12-31(48)49)33(51)43-26(18-23-19-39-21-41-23)34(52)44-27(17-22-7-3-2-4-8-22)36(54)46-15-5-9-28(46)35(53)40-20-30(47)45-14-6-10-29(45)37(55)56/h2-4,7-8,19,21,24-29H,5-6,9-18,20,38H2,1H3,(H,39,41)(H,40,53)(H,42,50)(H,43,51)(H,44,52)(H,48,49)(H,55,56)/t24-,25-,26-,27-,28-,29-/m0/s1
2.1.3 InChI Key
AFEHBIGDWIGTEH-AQRCPPRCSA-N
2.2 Other Identifiers
2.2.1 UNII
I5FAL2585H
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Acth (4-7), Pro-gly-pro-

2. Acth (4-7), Prolyl-glycyl-proline-

3. Pro-gly-pro-acth (4-7)

2.3.2 Depositor-Supplied Synonyms

1. 80714-61-0

2. Acth (4-7), Pro-gly-pro-

3. Mehfpgp

4. Met-glu-his-phe-pro-gly-pro

5. I5fal2585h

6. Acth (4-7), Prolyl-glycyl-proline-

7. Pro-gly-pro-acth (4-7)

8. Unii-i5fal2585h

9. L-methionyl-l-alpha-glutamyl-l-histidyl-l-phenylalanyl-l-prolylglycyl-l-proline

10. (2s)-1-[2-[[(2s)-1-[(2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-4-methylsulfanylbutanoyl]amino]-4-carboxybutanoyl]amino]-3-(1h-imidazol-5-yl)propanoyl]amino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic Acid

11. L-proline, 1-(n-(1-(n-(n-(n-l-methionyl-l-alpha-glutamyl)-l-histidyl)-l-phenylalanyl)-l-prolyl)glycyl)-

12. Semax?

13. H-met-glu-his-phe-pro-gly-pro-oh

14. Schembl7200319

15. Glxc-25922

16. Hy-p1146

17. Akos040744795

18. At42448

19. Da-77788

20. Met-glu-his-phe-pro-gly-pro [who-dd]

21. Cs-0028296

22. Methionyl-glutamyl-histidyl-phenylalanyl-prolyl-glycyl-proline

23. L-proline, L-methionyl-l-.alpha.-glutamyl-l-histidyl-l-phenylalanyl-l-prolylglycyl-

24. L-proline, L-methionyl-l-alpha-glutamyl-l-histidyl-l-phenylalanyl-l-prolylglycyl-

2.4 Create Date
2006-10-25
3 Chemical and Physical Properties
Molecular Weight 813.9 g/mol
Molecular Formula C37H51N9O10S
XLogP3-2.8
Hydrogen Bond Donor Count8
Hydrogen Bond Acceptor Count13
Rotatable Bond Count21
Exact Mass Da
Monoisotopic Mass Da
Topological Polar Surface Area312
Heavy Atom Count57
Formal Charge0
Complexity1450
Isotope Atom Count0
Defined Atom Stereocenter Count6
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Pharmacology and Biochemistry
4.1 MeSH Pharmacological Classification

Enzyme Inhibitors

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)


Neuroprotective Agents

Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)


Nootropic Agents

Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)


ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty